In this double-blind , placebo-controlled , crossover study , adults with ADHD-PI were randomized 1:1:1 to receive a single dose of MDX 1400 mg , MDX 700 mg , and placebo ( ClinicalTrials.gov identifier : NCT01685281 ) .